Projecting another year record-setting year, the pace of approved and tentatively approved ANDAs continued in October and November — 101 and 107, respectively — according to GDUFA’s activities report. Snapshots of the current workload for original ANDAs, including applications pending review by FDA and pending responses by applicants, are published in a quarterly update.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
